Activity: Development of hormone-specific (FSH and LH) innovative biomolecules for the treatment of male and female fertility disorders.
Sector: Biotechnology & Nutrition
Investment date: February 2019
Fund: Loire Valley Invest / Go Capital Amorçage II
